These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28550310)

  • 41. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
    Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
    Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strong conservation of inbred mouse strain microRNA loci but broad variation in brain microRNAs due to RNA editing and isomiR expression.
    Trontti K; Väänänen J; Sipilä T; Greco D; Hovatta I
    RNA; 2018 May; 24(5):643-655. PubMed ID: 29445025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ADAR-related activation of adenosine-to-inosine RNA editing during regeneration.
    Witman NM; Behm M; Ohman M; Morrison JI
    Stem Cells Dev; 2013 Aug; 22(16):2254-67. PubMed ID: 23534823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease.
    Khermesh K; D'Erchia AM; Barak M; Annese A; Wachtel C; Levanon EY; Picardi E; Eisenberg E
    RNA; 2016 Feb; 22(2):290-302. PubMed ID: 26655226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteogenomics of Adenosine-to-Inosine RNA Editing in the Fruit Fly.
    Kuznetsova KG; Kliuchnikova AA; Ilina IU; Chernobrovkin AL; Novikova SE; Farafonova TE; Karpov DS; Ivanov MV; Goncharov AO; Ilgisonis EV; Voronko OE; Nasaev SS; Zgoda VG; Zubarev RA; Gorshkov MV; Moshkovskii SA
    J Proteome Res; 2018 Nov; 17(11):3889-3903. PubMed ID: 30298734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipopolysaccharide enhances ADAR2 which drives Hirschsprung's disease by impairing miR-142-3p biogenesis.
    Peng L; Zhang H; Su Y; Shen Q; Du C; Xie H; Li H; Yan J; Shen Z; Jiang W; Xia Y; Xu X; Tang W
    J Cell Mol Med; 2018 Sep; 22(9):4045-4055. PubMed ID: 29956457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory factors governing adenosine-to-inosine (A-to-I) RNA editing.
    Hong H; Lin JS; Chen L
    Biosci Rep; 2015 Mar; 35(2):. PubMed ID: 25662729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A-to-I editing challenger or ally to the microRNA process.
    Ohman M
    Biochimie; 2007 Oct; 89(10):1171-6. PubMed ID: 17628290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure-mediated modulation of mRNA abundance by A-to-I editing.
    Brümmer A; Yang Y; Chan TW; Xiao X
    Nat Commun; 2017 Nov; 8(1):1255. PubMed ID: 29093448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Editing inducer elements increases A-to-I editing efficiency in the mammalian transcriptome.
    Daniel C; Widmark A; Rigardt D; Öhman M
    Genome Biol; 2017 Oct; 18(1):195. PubMed ID: 29061182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accumulation of nuclear ADAR2 regulates adenosine-to-inosine RNA editing during neuronal development.
    Behm M; Wahlstedt H; Widmark A; Eriksson M; Öhman M
    J Cell Sci; 2017 Feb; 130(4):745-753. PubMed ID: 28082424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine deamination in human transcripts generates novel microRNA binding sites.
    Borchert GM; Gilmore BL; Spengler RM; Xing Y; Lanier W; Bhattacharya D; Davidson BL
    Hum Mol Genet; 2009 Dec; 18(24):4801-7. PubMed ID: 19776031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. To edit or not to edit: regulation of ADAR editing specificity and efficiency.
    Deffit SN; Hundley HA
    Wiley Interdiscip Rev RNA; 2016; 7(1):113-27. PubMed ID: 26612708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers.
    Liu WH; Chen CH; Yeh KH; Li CL; Wu YJ; Chen DS; Chen PJ; Yeh SH
    PLoS One; 2013; 8(12):e81922. PubMed ID: 24386085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer.
    Cho CJ; Myung SJ; Chang S
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A robust model for quantitative prediction of the silencing efficacy of wild-type and A-to-I edited miRNAs.
    Tian S; Terai G; Kobayashi Y; Kimura Y; Abe H; Asai K; Ui-Tei K
    RNA Biol; 2020 Feb; 17(2):264-280. PubMed ID: 31601146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mammalian reporter system for fast and quantitative detection of intracellular A-to-I RNA editing levels.
    Gommans WM; McCane J; Nacarelli GS; Maas S
    Anal Biochem; 2010 Apr; 399(2):230-6. PubMed ID: 20051222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A-to-I editing in the miRNA seed region regulates target mRNA selection and silencing efficiency.
    Kume H; Hino K; Galipon J; Ui-Tei K
    Nucleic Acids Res; 2014 Sep; 42(15):10050-60. PubMed ID: 25056317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature.
    Cesarini V; Silvestris DA; Galeano F; Tassinari V; Martini M; Locatelli F; Gallo A
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiRNA editing.
    Dupuis DE; Maas S
    Methods Mol Biol; 2010; 667():267-79. PubMed ID: 20827540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.